| Concord Biotech Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 543960 |
NSE Symbol : CONCORDBIO |
P/E(TTM) : 75.12 |
|
ISIN Demat : INE338H01029 |
Div & Yield% : 0.39 |
EPS(TTM) : 30.06 |
|
Book Value(₹) : 145.80 |
Market Cap(₹Cr) : 23,624.43 |
Face Value(₹) : 1.00 |
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 215.80 | 318.97 | 240.80 | 262.35 | 194.83 | 272.59 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 215.80 | 318.97 | 240.80 | 262.35 | 194.83 | 272.59 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 10.31 | 10.81 | 8.19 | 8.13 | 6.65 | 12.20 |
| Total Income | 226.11 | 329.78 | 248.98 | 270.47 | 201.48 | 284.79 |
| Total Expenditure | 134.52 | 184.68 | 134.87 | 143.16 | 122.68 | 143.52 |
| PBIDT | 91.59 | 145.10 | 114.12 | 127.32 | 78.81 | 141.26 |
| Interest | 0.24 | 0.46 | 0.50 | 0.84 | 0.75 | 1.45 |
| PBDT | 91.35 | 144.64 | 113.62 | 126.47 | 78.05 | 139.81 |
| Depreciation | 13.18 | 13.72 | 13.54 | 13.30 | 13.04 | 14.18 |
| Tax | 19.39 | 29.98 | 25.80 | 27.76 | 16.30 | 31.17 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.53 | 3.73 | -0.27 | 0.93 | 0.24 | 0.95 |
| Reported Profit After Tax | 58.24 | 97.21 | 74.55 | 84.49 | 48.47 | 93.51 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 58.24 | 97.21 | 74.55 | 84.49 | 48.47 | 93.51 |
| EPS (Unit Curr.) | 5.57 | 9.29 | 7.13 | 8.08 | 4.63 | 8.94 |
| EPS (Adj) (Unit Curr.) | 5.57 | 9.29 | 7.13 | 8.08 | 4.63 | 8.94 |
| Calculated EPS (Unit Curr.) | 5.57 | 9.29 | 7.13 | 8.08 | 4.63 | 8.94 |
| Calculated EPS (Adj) (Unit Curr.) | 5.57 | 9.29 | 7.13 | 8.08 | 4.63 | 8.94 |
| Calculated EPS (Ann.) (Unit Curr.) | 22.27 | 37.17 | 28.51 | 32.31 | 18.53 | 35.75 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 22.27 | 37.17 | 28.51 | 32.31 | 18.53 | 35.75 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 10.46 | 10.46 | 10.46 | 10.46 | 10.46 | 10.46 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 42.44 | 45.49 | 47.39 | 48.53 | 40.45 | 51.82 |
| PBDTM(%) | 42.33 | 45.35 | 47.18 | 48.21 | 40.06 | 51.29 |
| PATM(%) | 26.99 | 30.48 | 30.96 | 32.21 | 24.88 | 34.30 |